## Abstract ## Objective To study the relationship between functional variants in the serotonin transporter gene (__SLC6A4__) and selective serotonin reuptake inhibitor (SSRI)‐associated sexual dysfunction. ## Methods One hundred fifteen subjects aged 18–40 years and currently being treated with
Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI)
✍ Scribed by Peter Eichhammer; Berthold Langguth; Rainer Wiegand; Alexander Kharraz; Ulrich Frick; Göran Hajak
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 124 KB
- Volume
- 166
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The intensity dependence of the auditory evoked potential (AEP) has been suggested as an indicator of central serotonergic function, a strong intensity dependence presumably reflecting low serotonergic activity. As individual differences in serotonergic neurotransmission can be accounted for in part
It has been suggested that the serotonin transporter (5-hydroxytryptamine-transporter or 5-HTT) may be involved in the pathogenesis of affective disorders. Recently, Collier et al. (1996) found that the frequency of the low-activity short variant (s) of the 5-HTT-linked polymorphic region (5-HTTLPR)